p53RFP Polyclonal Antibody

RNF144B

p53 is the most commonly mutated gene in human cancer identified to date. Expression of p53 leads to inhibition of cell growth by preventing progression of cells from G1 to S phase of the cell cycle. Most importantly, p53 functions to cause arrest of cells in the G1 phase of the cell cycle following any exposure of cells to DNA-damaging agents. The MDM2 (murine double minute-2) protein was initially identified as an oncogene in a murine transformation system. MDM2 functions to bind p53 and block p53-mediated transactivation of cotransfected reporter constructs. The MDM2 gene is amplified in a high percentage of human sarcomas that retain wildtype p53 and tumor cells that overexpress MDM2 can tolerate high levels of p53 expression. Another p53 target protein is the p53-inducible RING finger protein (p53RFP), an auto-ubiquitinylated protein acting as an E3 ubiquitin ligase. p53RFP, also designated IBRDC2 in mouse and rat, receives ubiquitin from specific E2 ubiquitin-conjugating enzymes and transfers it to substrates that promote their degradation by the proteasome. p53RFP may mediate re-entry into the cell cycle.

PBS with 0.05% sodium azide and 50% glycerol, PH7.4

34kDa

0.4 mg/mL

Unconjugated

WB 1:200-1:1000, IHC 1:50-1:200

Recombinant protein of human RNF144B

Affinity purification

bA528A10.3;E3 ubiquitin protein ligase RNF144B;E3 ubiquitin-protein ligase RNF144B;IBR domain containing 2;IBR domain containing protein 2;IBR domain-containing protein 2;IBRDC 2;IBRDC2;KIAA0161;MGC71786;OTTHUMP00000016079;OTTHUMP00000016080;OTTHUMP00000039360;p53 inducible RING finger protein;p53-inducible RING finger protein;p53RFP;PIR2;R144B;Ring finger 144B;RING finger protein 144B;RNF 144B;RNF144B

Q7Z419